Milestone Pharmaceuticals Inc. Earnings Per Share (Basic)
Milestone Pharmaceuticals Inc. (MIST) reported Earnings Per Share (Basic) of -$0.21 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-12
- Milestone Pharmaceuticals Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$0.21.
- Milestone Pharmaceuticals Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$0.20.
- Milestone Pharmaceuticals Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$0.12.
- Milestone Pharmaceuticals Inc. earnings per share, basic for the quarter ending 2025-06-30 was -$0.20.
- Milestone Pharmaceuticals Inc. earnings per share, basic for fiscal 2025 was -$0.75.
- Milestone Pharmaceuticals Inc. earnings per share, basic for fiscal 2024 was -$0.67.
- Milestone Pharmaceuticals Inc. earnings per share, basic for fiscal 2023 was -$1.39.
- Milestone Pharmaceuticals Inc. earnings per share, basic for fiscal 2022 was -$1.38.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.21 10-Q · filed 2026-08-12 | -$0.41 10-Q · filed 2026-08-12 | ||
| 2026-03-31 | -$0.20 10-Q · filed 2026-05-13 | |||
| 2025-12-31 | -$0.75 10-K · filed 2026-03-20 | |||
| 2025-09-30 | -$0.12 10-Q · filed 2025-11-12 | -$0.60 10-Q · filed 2025-11-12 | ||
| 2025-06-30 | -$0.20 10-Q · filed 2026-08-12 | -$0.51 10-Q · filed 2026-08-12 | ||
| 2025-03-31 | -$0.31 10-Q · filed 2026-05-13 | |||
| 2024-12-31 | -$0.67 10-K · filed 2026-03-20 | |||
| 2024-09-30 | -$0.14 10-Q · filed 2025-11-12 | -$0.48 10-Q · filed 2025-11-12 | ||
| 2024-06-30 | -$0.14 10-Q · filed 2025-08-12 | -$0.34 10-Q · filed 2025-08-12 | ||
| 2024-03-31 | -$0.21 10-Q · filed 2025-05-14 | |||
| 2023-12-31 | -$1.39 10-K · filed 2025-03-13 | |||
| 2023-09-30 | -$0.35 10-Q · filed 2024-11-12 | -$1.07 10-Q · filed 2024-11-12 | ||
| 2023-06-30 | -$0.37 10-Q · filed 2024-08-08 | -$0.72 10-Q · filed 2024-08-08 | ||
| 2023-03-31 | -$0.35 10-Q · filed 2024-05-13 | |||
| 2022-12-31 | -$1.38 10-K · filed 2024-03-21 | |||
| 2022-09-30 | -$0.34 10-Q · filed 2023-11-13 | -$1.07 10-Q · filed 2023-11-13 | ||
| 2022-06-30 | -$0.39 10-Q · filed 2023-08-10 | -$0.73 10-Q · filed 2023-08-10 | ||
| 2022-03-31 | -$0.33 10-Q · filed 2023-05-11 | |||
| 2021-12-31 | -$1.02 10-K · filed 2023-03-29 | |||
| 2021-09-30 | -$0.34 10-Q · filed 2022-11-10 | -$0.62 10-Q · filed 2022-11-10 | ||
| 2021-06-30 | $0.02 10-Q · filed 2022-08-10 | -$0.28 10-Q · filed 2022-08-10 | ||
| 2021-03-31 | -$0.30 10-Q · filed 2022-05-12 | |||
| 2020-12-31 | -$1.70 10-K · filed 2022-03-24 | |||
| 2020-06-30 | -$0.53 10-Q · filed 2021-08-11 | -$1.20 10-Q · filed 2021-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B | |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B |